Section Arrow
Quote
BIO B.NYSE
- Bio-Rad Laboratories
Quotes are at least 15-min delayed:2026/08/05 16:58 EDT
After Hours
Last
 --
-- (--)
Bid
0.0001
Ask
440.79
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 --
-- (--)
Day High 
-- 
Prev. Close
337 
1-M High
337 
Volume 
-- 
Bid
0.0001
Ask
440.79
Day Low
-- 
Open
-- 
1-M Low
293.37 
Market Cap 
9.02B 
Currency 美元 
P/E 56.07 
%Yield -- 
10-SMA 314.9 
20-SMA 309.99 
50-SMA 302.62 
52-W High 337 
52-W Low 244.54 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
6.01/9.08
Enterprise Value
10.37B
Balance Sheet
Book Value Per Share
256.01
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
2.58B
Operating Revenue Per Share
101.65
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
After Hours 1.25 +0.01 +0.81%
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
After Hours 48.7 +0.96 +2.01%
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
After Hours 11.25 -0.85 -7.02%
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
After Hours 0.683 -0.056 -7.58%
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
After Hours 1.26 -0.04 -3.08%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.